宽松与限制性输血阈值对极低出生体重儿生存及神经认知结局的影响:ETTNO随机临床试验
该随机临床试验在36个欧洲III/IV级新生儿重症监护病房纳入1013例出生体重400-999 g、生后<72小时的婴儿,随机分为宽松(n=492)或限制性(n=521)输血阈值组,阈值基于生后日龄和当前健康状态。主要结局为24月龄校正年龄时死亡或残疾(认知缺陷、脑瘫或严重视听觉障碍)。宽松组vs限制性组主要结局发生率44.4% vs 42.9%,差异1.6%(95%CI -4.8%至7.9%;P=0.72),无统计学显著差异。结论:在出生体重<1000 g的婴儿中,宽松输血策略未降低死亡或残疾风险。
要点
- 在出生体重<1000 g婴儿中,宽松vs限制性输血阈值组24月龄死亡或残疾发生率44.4% vs 42.9%,差异1.6%(95%CI -4.8%至7.9%;P=0.72),无显著差异。
- 宽松组vs限制性组任何输血发生率81.3% vs 60.5%,中位输血量40 mL(IQR 16-73)vs 19 mL(IQR 0-46),宽松组每周平均红细胞压积高3个百分点。
- 宽松vs限制性组24月龄死亡8.3% vs 9.0%(差异-0.7%,95%CI -4.3%至2.9%;P=0.70),认知缺陷37.6% vs 34.4%(差异3.2%,95%CI -3.3%至9.6%;P=0.47),脑瘫4.3% vs 5.6%(差异-1.3%,95%CI -4.2%至1.5%;P=0.37)。
- 宽松vs限制性组需手术干预的坏死性小肠结肠炎4.1% vs 5.4%,支气管肺发育不良28.4% vs 26.0%,需治疗视网膜病变8.7% vs 7.7%,随访生长无显著差异。
适用人群与场景
- 出生体重400-999 g、生后<72小时的婴儿,纳入36个欧洲III/IV级新生儿重症监护病房。
诊断标准与关键阈值
- 输血阈值基于婴儿生后日龄和当前健康状态设定,宽松组与限制性组采用不同阈值(原文未列出具体血红蛋白/红细胞压积界值)。
处置流程与药物剂量
- 任何输血发生率:宽松组81.3%(400/492)vs 限制性组60.5%(315/521)。
- 中位输血量:宽松组40 mL(IQR 16-73 mL)vs 限制性组19 mL(IQR 0-46 mL);宽松组每周平均红细胞压积高3个百分点。
研究设计与关键结果
- 多中心随机临床试验,36个欧洲III/IV级新生儿重症监护病房,纳入1013例出生体重400-999 g、生后<72小时婴儿,随机分为宽松输血阈值组(n=492)或限制性输血阈值组(n=521);中位胎龄26.3周(IQR 24.9-27.6),女性509例(50.2%);928例(91.6%)完成试验。
- 主要结局(24月龄校正年龄死亡或残疾):宽松组44.4%(200/450)vs 限制性组42.9%(205/478),差异1.6%(95%CI -4.8%至7.9%;P=0.72)。
- 24月龄死亡:宽松组8.3%(38/460)vs 限制性组9.0%(44/491),差异-0.7%(95%CI -4.3%至2.9%;P=0.70)。
- 认知缺陷:宽松组37.6%(154/410)vs 限制性组34.4%(148/430),差异3.2%(95%CI -3.3%至9.6%;P=0.47)。
- 脑瘫:宽松组4.3%(18/419)vs 限制性组5.6%(25/443),差异-1.3%(95%CI -4.2%至1.5%;P=0.37)。
- 需手术干预的坏死性小肠结肠炎:宽松组4.1%(20/492)vs 限制性组5.4%(28/518);支气管肺发育不良:宽松组28.4%(130/458)vs 限制性组26.0%(126/485);需治疗视网膜病变:宽松组8.7%(41/472)vs 限制性组7.7%(38/492);随访生长两组无显著差异。
证据类型、等级与局限
- 证据类型:随机临床试验(RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在出生体重<1000 g婴儿中,宽松输血阈值与限制性输血阈值相比未降低24月龄死亡或残疾风险,作者结论为宽松策略未减少死亡或残疾的可能性。
- 宽松策略使任何输血发生率从60.5%升至81.3%,中位输血量从19 mL升至40 mL,每周平均红细胞压积高3个百分点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Red blood cell transfusions are commonly administered to infants weighing less than 1000 g at birth. Evidence-based transfusion thresholds have not been established. Previous studies have suggested higher rates of cognitive impairment with restrictive transfusion thresholds.
OBJECTIVE: To compare the effect of liberal vs restrictive red blood cell transfusion strategies on death or disability.
DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted in 36 level III/IV neonatal intensive care units in Europe among 1013 infants with birth weights of 400 g to 999 g at less than 72 hours after birth; enrollment took place between July 14, 2011, and November 14, 2014, and follow-up was completed by January 15, 2018.
INTERVENTIONS: Infants were randomly assigned to liberal (n = 492) or restrictive (n = 521) red blood cell transfusion thresholds based on infants' postnatal age and current health state.
MAIN OUTCOME AND MEASURES: The primary outcome, measured at 24 months of corrected age, was death or disability, defined as any of cognitive deficit, cerebral palsy, or severe visual or hearing impairment. Secondary outcome measures included individual components of the primary outcome, complications of prematurity, and growth.
RESULTS: Among 1013 patients randomized (median gestational age at birth, 26.3 [interquartile range {IQR}, 24.9-27.6] weeks; 509 [50.2%] females), 928 (91.6%) completed the trial. Among infants in the liberal vs restrictive transfusion thresholds groups, respectively, incidence of any transfusion was 400/492 (81.3%) vs 315/521 (60.5%); median volume transfused was 40 mL (IQR, 16-73 mL) vs 19 mL (IQR, 0-46 mL); and weekly mean hematocrit was 3 percentage points higher with liberal thresholds. Among infants in the liberal vs restrictive thresholds groups, the primary outcome occurred in 200/450 (44.4%) vs 205/478 (42.9%), respectively, for a difference of 1.6% (95% CI, -4.8% to 7.9%; P = .72). Death by 24 months occurred in 38/460 (8.3%) vs 44/491 (9.0%), for a difference of -0.7% (95% CI, -4.3% to 2.9%; P = .70), cognitive deficit was observed in 154/410 (37.6%) vs 148/430 (34.4%), for a difference of 3.2% (95% CI, -3.3% to 9.6%; P = .47), and cerebral palsy occurred in 18/419 (4.3%) vs 25/443 (5.6%), for a difference of -1.3% (95% CI, -4.2% to 1.5%; P = .37), in the liberal vs the restrictive thresholds groups, respectively. In the liberal vs restrictive thresholds groups, necrotizing enterocolitis requiring surgical intervention occurred in 20/492 (4.1%) vs 28/518 (5.4%); bronchopulmonary dysplasia occurred in 130/458 (28.4%) vs 126/485 (26.0%); and treatment for retinopathy of prematurity was required in 41/472 (8.7%) vs 38/492 (7.7%). Growth at follow-up was also not significantly different between groups.
CONCLUSIONS AND RELEVANCE: Among infants with birth weights of less than 1000 g, a strategy of liberal blood transfusions compared with restrictive transfusions did not reduce the likelihood of death or disability at 24 months of corrected age.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01393496.
参考来源
- Franz AR, Engel C, Bassler D, et al. Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial. JAMA. 2020. PMID: 32780138. doi:10.1001/jama.2020.10690
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。